References
- Suzuki R, Takeuchi K, Ohshima K, Nakamura S. Extranodal NK/T-cell lymphoma: diagnosis and treatment cues. Hematol Oncol 2008;26:66–72.
- Oshimi K. Progress in understanding and managing natural killer-cell malignancies. Br J Haematol 2007;139:532–544.
- Swerdlow SH, Campo E, Harris NL, et al WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. Lyon: IARC; 2008.
- Au WY, Weisenburger DD, Intragumtornchai T, et al Clinical differences between nasal and extranasal NK/T-cell lymphoma: a study of 136 cases from the International Peripheral T-cell Lymphoma Project. Blood 2009;113:3931–3937.
- Lee J, Au WY, Park MJ, et al Autologous hematopoietic stem cell transplantation in extranodal natural killer/T cell lymphoma: a multinational, multicenter, matched controlled study. Biol Blood Marrow Transplant 2008;14:1356–1364.
- Yamaguchi M, Suzuki R, Kwong YL, et al Phase I study of dexamethasone, methotrexate, ifosfamide, L-asparaginase, and etoposide (SMILE) chemotherapy for advanced-stage, relapsed or refractory extranodal natural killer (NK)/T-cell lymphoma and leukemia. Cancer Sci 2008;99:1016–1020.
- Chim CS, Ooi GC, Shek TW, et al Lethal midline granuloma revisited: nasal T/natural-killer cell lymphoma. J Clin Oncol 1999;17:1322–1325.
- Schrader C, Janssen D, Kneba M, Lennert K. A 38-year history of natural-killer-cell lymphoma. N Engl J Med 2004;350:418–419.
- Lee J, Suh C, Park YH, et al Extranodal natural killer T-cell lymphoma, nasal-type: a prognostic model from a retrospective multicenter study. J Clin Oncol 2006;24:612–618.
- Chim CS, Ma SY, Au WY, et al Primary nasal natural killer cell lymphoma: long-term treatment outcome and relationship with the International Prognostic Index. Blood 2004;103:216–221.
- Cohen JI, Kimura H, Nakamura S, Ko YH, Jaffe ES. Epstein-Barr virus-associated lymphoproliferative disease in non-immunocompromised hosts: a status report and summary of an international meeting, 8–9 September 2008. Ann Oncol 2009;20:1472–1482.